$ACHC
Acadia Healthcare Company, Inc.

2017 Q2 Form 10-Q Financial Statement

#000119312517240235 Filed on July 28, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $715.9M $756.5M
YoY Change -5.37% 66.77%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $478.0M $510.3M
YoY Change -6.33% 68.92%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $35.20M $36.70M
YoY Change -4.09% 146.31%
% of Gross Profit
Operating Expenses $649.7M $682.7M
YoY Change -4.84% 68.86%
Operating Profit $162.2M $172.2M
YoY Change -5.81% 62.78%
Interest Expense -$43.50M -$48.70M
YoY Change -10.68% 67.93%
% of Operating Profit -26.82% -28.28%
Other Income/Expense, Net
YoY Change
Pretax Income $66.22M $73.85M
YoY Change -10.34% 49.63%
Income Tax $16.58M $18.26M
% Of Pretax Income 25.04% 24.73%
Net Earnings $49.63M $56.45M
YoY Change -12.07% 66.78%
Net Earnings / Revenue 6.93% 7.46%
Basic Earnings Per Share $0.57 $0.65
Diluted Earnings Per Share $0.57 $0.65
COMMON SHARES
Basic Shares Outstanding 86.95M 86.55M shares
Diluted Shares Outstanding 87.08M 86.88M shares

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $79.40M $30.70M
YoY Change 158.63% -11.27%
Cash & Equivalents $79.43M $30.72M
Short-Term Investments
Other Short-Term Assets $91.97M $76.52M
YoY Change 20.19% 8.81%
Inventory $4.917M $4.819M
Prepaid Expenses $26.00M $27.97M
Receivables $288.1M $285.1M
Other Receivables $30.69M $22.46M
Total Short-Term Assets $459.5M $392.4M
YoY Change 17.11% 20.39%
LONG-TERM ASSETS
Property, Plant & Equipment $2.866B $3.275B
YoY Change -12.47% 124.99%
Goodwill $2.710B $2.832B
YoY Change -4.3% 45.54%
Intangibles $84.98M $85.00M
YoY Change -0.02% 45.26%
Long-Term Investments
YoY Change
Other Assets $59.64M $42.01M
YoY Change 41.97% -60.59%
Total Long-Term Assets $5.769B $6.292B
YoY Change -8.32% 74.76%
TOTAL ASSETS
Total Short-Term Assets $459.5M $392.4M
Total Long-Term Assets $5.769B $6.292B
Total Assets $6.228B $6.684B
YoY Change -6.83% 70.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $81.40M $108.2M
YoY Change -24.78% 84.3%
Accrued Expenses $37.55M $40.57M
YoY Change -7.43% -72.16%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $34.81M $73.41M
YoY Change -52.59% 89.93%
Total Short-Term Liabilities $347.0M $419.8M
YoY Change -17.35% 72.68%
LONG-TERM LIABILITIES
Long-Term Debt $3.240B $3.578B
YoY Change -9.44% 86.9%
Other Long-Term Liabilities $171.7M $151.6M
YoY Change 13.22% 84.42%
Total Long-Term Liabilities $3.412B $3.730B
YoY Change -8.52% 86.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $347.0M $419.8M
Total Long-Term Liabilities $3.412B $3.730B
Total Liabilities $3.834B $4.235B
YoY Change -9.49% 87.4%
SHAREHOLDERS EQUITY
Retained Earnings $313.3M $296.1M
YoY Change 5.81% 97.58%
Common Stock $2.509B $2.483B
YoY Change 1.05% 58.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.377B $2.436B
YoY Change
Total Liabilities & Shareholders Equity $6.228B $6.684B
YoY Change -6.83% 70.25%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income $49.63M $56.45M
YoY Change -12.07% 66.78%
Depreciation, Depletion And Amortization $35.20M $36.70M
YoY Change -4.09% 146.31%
Cash From Operating Activities $130.6M $124.2M
YoY Change 5.15% 70.37%
INVESTING ACTIVITIES
Capital Expenditures -$87.40M -$101.3M
YoY Change -13.72% 42.88%
Acquisitions
YoY Change
Other Investing Activities -$800.0K -$103.3M
YoY Change -99.23% -56.61%
Cash From Investing Activities -$88.20M -$204.6M
YoY Change -56.89% -33.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -9.500M 81.10M
YoY Change -111.71% -64.62%
NET CHANGE
Cash From Operating Activities 130.6M 124.2M
Cash From Investing Activities -88.20M -204.6M
Cash From Financing Activities -9.500M 81.10M
Net Change In Cash 32.90M 700.0K
YoY Change 4600.0% -110.14%
FREE CASH FLOW
Cash From Operating Activities $130.6M $124.2M
Capital Expenditures -$87.40M -$101.3M
Free Cash Flow $218.0M $225.5M
YoY Change -3.33% 56.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
37554000
CY2014Q4 achc Consolidated Funded Debt Maximum
ConsolidatedFundedDebtMaximum
40000000
CY2017Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
87870122 shares
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30716000
CY2017Q2 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
4224000
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
40992000
CY2017Q2 us-gaap Assets Current
AssetsCurrent
459512000
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
288106000
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
278753000
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2508064000
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
81399000
CY2017Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
11675000
CY2017Q2 us-gaap Assets
Assets
6228022000
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
79434000
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000 shares
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-445400000
CY2017Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9138000
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
59637000
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
171678000
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86991051 shares
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
86991051 shares
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
870000
CY2017Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
23581000
CY2017Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
3719000
CY2017Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
74467000
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
97819000
CY2017Q2 us-gaap Derivative Instruments And Hedges Noncurrent
DerivativeInstrumentsAndHedgesNoncurrent
43753000
CY2017Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3247000
CY2017Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3247000
CY2017Q2 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
43800000
CY2017Q2 us-gaap Goodwill
Goodwill
2710333000
CY2017Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
11983000
CY2017Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
84982000
CY2017Q2 us-gaap Insurance Receivable For Malpractice Current
InsuranceReceivableForMalpracticeCurrent
6472000
CY2017Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
84982000
CY2017Q2 us-gaap Inventory Net
InventoryNet
4917000
CY2017Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
88229000
CY2017Q2 us-gaap Interest Payable Current
InterestPayableCurrent
35833000
CY2017Q2 us-gaap Liabilities
Liabilities
3833585000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6228022000
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
346967000
CY2017Q2 us-gaap Long Term Debt
LongTermDebt
3275278000
CY2017Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
34805000
CY2017Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3240473000
CY2017Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
39 State
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
132944000
CY2017Q2 us-gaap Other Assets Current
OtherAssetsCurrent
91972000
CY2017Q2 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
1907000
CY2017Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
30692000
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
26001000
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2866086000
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3144839000
CY2017Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
17577000
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
313326000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
8200000 shares
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
4151000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
4434974 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4366000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
423995 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
48.29
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1013203 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
48.23
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
2376860000
CY2017Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
10939000
CY2017Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0
CY2017Q2 achc Intangible Assets Accumulated Amortization Carrying Amount
IntangibleAssetsAccumulatedAmortizationCarryingAmount
3247000
CY2017Q2 achc Debt Instrument Unamortized Issuance Costs Discount Premium Net
DebtInstrumentUnamortizedIssuanceCostsDiscountPremiumNet
55072000
CY2017Q2 achc Workers Compensation Deposits
WorkersCompensationDeposits
10000000
CY2017Q2 achc Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Amortization
IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedAmortization
0
CY2017Q2 achc Number Of Beds
NumberOfBeds
17300 Beds
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11215000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
20717000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
694743 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
42.87
CY2016Q1 us-gaap Common Stock Discount On Shares
CommonStockDiscountOnShares
15800000
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
61.00
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11500000 shares
CY2016Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
2732000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
38916000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
37323000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
427927000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
263327000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
214589000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2496288000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
80034000
CY2016Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
11672000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-549570000
CY2016Q4 us-gaap Assets
Assets
6024726000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57063000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86688199 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
86688199 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
867000
CY2016Q4 us-gaap Goodwill
Goodwill
2681188000
CY2016Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
11714000
CY2016Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
83310000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
28805000
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
3780000
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
78520000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
105068000
CY2016Q4 us-gaap Derivative Instruments And Hedges Noncurrent
DerivativeInstrumentsAndHedgesNoncurrent
73509000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3247000
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3247000
CY2016Q4 us-gaap Insurance Receivable For Malpractice Current
InsuranceReceivableForMalpracticeCurrent
6472000
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
83310000
CY2016Q4 us-gaap Inventory Net
InventoryNet
4633000
CY2016Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
86557000
CY2016Q4 us-gaap Interest Payable Current
InterestPayableCurrent
33616000
CY2016Q4 us-gaap Liabilities
Liabilities
3839248000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6024726000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
342865000
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
3287809000
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
34805000
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3253004000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
122958000
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
107537000
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8283000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
51317000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
164859000
CY2016Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
2288000
CY2016Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
44975000
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
27455000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2703695000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2918284000
CY2016Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
17754000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
220139000
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
6111000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8166000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
288959 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
42.81
CY2016Q4 achc Number Of Beds To Be Sold
NumberOfBedsToBeSold
1000 Bed
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1000946 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
49.42
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
2167724000
CY2016Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
527000
CY2016Q4 achc Intangible Assets Accumulated Amortization Carrying Amount
IntangibleAssetsAccumulatedAmortizationCarryingAmount
3247000
CY2016Q4 achc Debt Instrument Unamortized Issuance Costs Discount Premium Net
DebtInstrumentUnamortizedIssuanceCostsDiscountPremiumNet
59816000
CY2016Q4 achc Workers Compensation Deposits
WorkersCompensationDeposits
10000000
CY2016Q4 achc Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Amortization
IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedAmortization
0
CY2016Q4 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2019-02-13
CY2016Q4 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
320000000
CY2016Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
700000
CY2016Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
685000000
dei Amendment Flag
AmendmentFlag
false
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1100000 shares
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
625000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14832000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4845000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
13171000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-829000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
22371000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-177000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
188758000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
188581000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Depreciation And Amortization
DepreciationAndAmortization
68814000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
17096000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.264 pure
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Type
DocumentType
10-Q
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.97
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
4297000
dei Document Period End Date
DocumentPeriodEndDate
2017-06-30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
dei Entity Registrant Name
EntityRegistrantName
Acadia Healthcare Company, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001520697
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-810000
us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
56348000
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
1414984000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
35231000
us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
19894000
us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
1395090000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
114700000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-9157000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4893000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
5257000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
22404000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1809000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30289000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-20457000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-86262000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
760016000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-177000
us-gaap Operating Income Loss
OperatingIncomeLoss
298589000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-146309000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
188435000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
104170000
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-14952000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
38406000
us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
8599000
us-gaap Operating Expenses
OperatingExpenses
1280390000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-23223000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
187606000
us-gaap Net Income Loss
NetIncomeLoss
84588000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
119122000
us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
-12100000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
166833000
achc Legal Accounting And Other Fees
LegalAccountingAndOtherFees
3601000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-6558000
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
22850000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
117521000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
5938000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2270000
us-gaap Profit Loss
ProfitLoss
84411000
us-gaap Professional Fees
ProfessionalFees
89730000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
17275000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
55.14
us-gaap Severance Costs1
SeveranceCosts1
9570000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
158126 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
42.99
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y3M19D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.33 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M6D
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
40.17
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.020 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y5M1D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.65
us-gaap Share Based Compensation
ShareBasedCompensation
14832000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1172000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
233000 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
62617 shares
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1426000
us-gaap Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
61200000
dei Trading Symbol
TradingSymbol
ACHC
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86997000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
138000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86859000 shares
achc New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption On Income Tax Provision
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionOnIncomeTaxProvision
1700000
achc Common Stock Withheld For Minimum Statutory Taxes
CommonStockWithheldForMinimumStatutoryTaxes
5104000
achc Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodAggregateIntrinsicValue
0
achc Common Stock Withheld For Minimum Statutory Taxes Net
CommonStockWithheldForMinimumStatutoryTaxesNet
3678000
achc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
105000
achc Goodwill Purchase Price Allocation And Other Changes
GoodwillPurchasePriceAllocationAndOtherChanges
6086000
achc Number Of Facilities
NumberOfFacilities
576 Facilities
achc Share Based Compensation Arrangement By Share Based Payment Stock Options Granted Term
ShareBasedCompensationArrangementByShareBasedPaymentStockOptionsGrantedTerm
P10Y
achc Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P9Y8M26D
achc New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption On Income Tax Provision As Percentage
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionOnIncomeTaxProvisionAsPercentage
0.015 pure
achc Share Based Compensation Arrangement By Share Based Payment Award
ShareBasedCompensationArrangementByShareBasedPaymentAward
0.25 pure
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1200000 shares
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4956000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
32372000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-2973000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
19501000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1173000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-155831000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-157004000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
64727000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
16821000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.239 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.97
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-8479000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
2504223000
us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
57894000
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
1394237000
us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
508000
us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
20876000
us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
1373361000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
106331000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3846000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
29101000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-261883000
us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
16500000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
151202000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-704000
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
28439000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
3728000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18982000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1582000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25371000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
7256000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-86472000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
749315000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
1604056000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
35273000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-890018000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
185831000
us-gaap Operating Expenses
OperatingExpenses
1267030000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
735140000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
182858000
us-gaap Net Income Loss
NetIncomeLoss
82133000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1173000
us-gaap Operating Income Loss
OperatingIncomeLoss
303238000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-237964000
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
23919000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
35511000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
683285000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
177718000
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
-508000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1084000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
216882000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-823000
us-gaap Profit Loss
ProfitLoss
80960000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1480000000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
158000000
us-gaap Professional Fees
ProfessionalFees
90283000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
29869000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
166000000
us-gaap Repayments Of Debt
RepaymentsOfDebt
1348389000
us-gaap Share Based Compensation
ShareBasedCompensation
13844000
us-gaap Severance Costs1
SeveranceCosts1
1421000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85052000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
304000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84748000 shares
achc Legal Accounting And Other Fees
LegalAccountingAndOtherFees
16101000
achc Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
685097000
achc Common Stock Withheld For Minimum Statutory Taxes Net
CommonStockWithheldForMinimumStatutoryTaxesNet
7365000
achc Advisory And Financing Commitment Fees
AdvisoryAndFinancingCommitmentFees
14850000
us-gaap Malpractice Insurance Annual Coverage Limit
MalpracticeInsuranceAnnualCoverageLimit
52000000
us-gaap Reinsurance Retention Policy Amount Retained
ReinsuranceRetentionPolicyAmountRetained
2000000
us-gaap Reinsurance Retention Policy Excess Retention Amount Reinsured
ReinsuranceRetentionPolicyExcessRetentionAmountReinsured
50000000
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y8M12D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
140250 shares
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M18D
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
31.92
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.014 pure
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y2M19D
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
18.96
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
57.98
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.33 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
57.13
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1530000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
503850 shares
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
57397 shares
CY2016 achc Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodAggregateIntrinsicValue
0
CY2016 achc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
297000
CY2016 achc Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P9Y3M11D
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1200000 shares
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
CY2016Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6074000
CY2016Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-854000
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-133104000
CY2016Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-133958000
CY2016Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
36752000
CY2016Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.247 pure
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
CY2016Q2 us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
31209000
CY2016Q2 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
767054000
CY2016Q2 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
98000
CY2016Q2 us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
10506000
CY2016Q2 us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
756548000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
73852000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18261000
CY2016Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-48758000
CY2016Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
408287000
CY2016Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
20467000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
682696000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
56445000
CY2016Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-854000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
172226000
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-189549000
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
23919000
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-213468000
CY2016Q2 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
16500000
CY2016Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
80955000
CY2016Q2 us-gaap Profit Loss
ProfitLoss
55591000
CY2016Q2 us-gaap Professional Fees
ProfessionalFees
50292000
CY2016Q2 us-gaap Share Based Compensation
ShareBasedCompensation
6888000
CY2016Q2 us-gaap Severance Costs1
SeveranceCosts1
1421000
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86876000 shares
CY2016Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
323000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86553000 shares
CY2016Q2 achc Legal Accounting And Other Fees
LegalAccountingAndOtherFees
4653000
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1600000 shares
CY2017Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
9052000
CY2017Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
8000
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
132622000
CY2017Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
132630000
CY2017Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
35201000
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.250 pure
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.57
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2017Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-810000
CY2017Q2 us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
28639000
CY2017Q2 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
725643000
CY2017Q2 us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
9747000
CY2017Q2 us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
715896000
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
66216000
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16578000
CY2017Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-43505000
CY2017Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
383595000
CY2017Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
19435000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
649680000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
49630000
CY2017Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
162220000
CY2017Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
82992000
CY2017Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-9084000
CY2017Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
92076000
CY2017Q2 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
-6500000
CY2017Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
83122000
CY2017Q2 us-gaap Profit Loss
ProfitLoss
49638000
CY2017Q2 us-gaap Professional Fees
ProfessionalFees
46321000
CY2017Q2 us-gaap Share Based Compensation
ShareBasedCompensation
7436000
CY2017Q2 us-gaap Severance Costs1
SeveranceCosts1
6938000
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87080000 shares
CY2017Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
126000 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86954000 shares
CY2017Q2 achc Legal Accounting And Other Fees
LegalAccountingAndOtherFees
2114000

Files In Submission

Name View Source Status
0001193125-17-240235-index-headers.html Edgar Link pending
0001193125-17-240235-index.html Edgar Link pending
0001193125-17-240235.txt Edgar Link pending
0001193125-17-240235-xbrl.zip Edgar Link pending
achc-20170630.xml Edgar Link completed
achc-20170630.xsd Edgar Link pending
achc-20170630_cal.xml Edgar Link unprocessable
achc-20170630_def.xml Edgar Link unprocessable
achc-20170630_lab.xml Edgar Link unprocessable
achc-20170630_pre.xml Edgar Link unprocessable
d407772d10q.htm Edgar Link pending
d407772dex311.htm Edgar Link pending
d407772dex312.htm Edgar Link pending
d407772dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending